Executive Summary
Across the 50 SEC Section 16 / Form 4 filings dated 2026-10-23, insider activity is dominated by routine equity compensation (RSU, phantom stock, and Class F/T unit awards to directors and officers), which carries little directional signal.
The meaningful signal sits in a smaller set of open-market trades: a cluster of notable sales by Travelers Companies executives (including a $13.2M sale by EVP Gregory Toczydlowski at $403.86 and a $3.66M sale by Jeffrey Klenk, both paired with option exercises), a $13.9M sale by 10% owner IGNITE AGGREGATOR LP in InnovAge, and a $3.55 private placement-style purchase cluster in Rent the Runway by Nexus Capital and CHS US Investments. Insider buying is concentrated in small-cap and fund names (AIM ImmunoTech, Cascade Real Assets, Vista Credit, Baozun, Waste Energy), while selling is concentrated in large-cap names with 10b5-1 plan disclosure. Several sales were executed under Rule 10b5-1 plans, which reduces their informational value as discretionary conviction signals. Note: the supplied enriched fields for period-over-period comparisons, forward-looking guidance, and capital allocation were not populated in the input, so trend analysis here is limited to transaction-level data and no guidance or margin claims are made.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Form 4
Tracking the trend? Catch up on the prior USA Insider Trading Pulse digest from October 22, 2026.
Investment Signals (11)
- Travelers Companies (TRV) (BEARISH)▲
EVP Toczydlowski sold 32,671 shares at $403.86 (~$13.2M) after exercising 34,771 options; EVP Rowland sold 5,000 at $405.62 (~$2.03M); EVP Klenk sold 9,016 at $405.57 (~$3.66M) after option exercises at $132.58; three executives selling in the same week at near-identical prices
- Rent the Runway (RENT) (BULLISH)▲
Director-affiliated Nexus Capital bought 632,922 Class A shares at $3.55 (~$2.25M) and 10% owner CHS US Investments bought 458,245 at $3.55 (~$1.63M), with Nexus holding 4,907,316 shares post-trade
- AIM ImmunoTech (AIM) (BULLISH)▲
CEO Thomas Equels bought 31,250 shares at $0.16 (~$5.09K), lifting holdings to 158,072; an insider open-market purchase in a micro-cap penny stock is a meaningful conviction signal
- Cascade Real Assets Fund ↓ (BULLISH)▲
Director Matthew Worley bought 41,909.531 Class I shares at $10.29 (~$431K), with holdings at 41,909.531 post-trade, signaling direct director alignment with the fund's NAV
- Vista Credit Strategic Lending ↓ (BULLISH)▲
CEO Gregory Galligan bought 5,143.644 shares at $19.44 (~$100K), bringing holdings to 43,446.644
- Baozun Inc. (BZUN) ↓ (BULLISH)▲
CEO Qiu Wenbin reported purchases of 5,700 ADSs at $3.50 (~$20K) appearing twice in the filing; holdings of 1,695,772 shares
- Waste Energy Corp. ↓ (NEUTRAL)▲
Chairman & CEO Scott Gallagher acquired 219,286 common shares at a nominal $0.00 price, most likely a grant or conversion rather than an arms-length purchase, with 9.5M shares held
- InnovAge Holding (INNV) (BEARISH)▲
10% owner IGNITE AGGREGATOR LP sold 1,500,000 shares at $9.25 (~$13.9M), still holding 101,076,555 shares; a large sponsor-level sale, though a small fraction of the stake
- Sea Ltd (SE) ↓ (MIXED)▲
President Zhimin Feng exercised 1,000,000 options at $15.00 (~$15M) and holds 2,003,969 shares post-exercise, while CCO Yanjun Wang sold ~569 shares at $76.09 under a 10b5-1 plan
- Kohl's (KSS) (BEARISH)▲
Chief Legal Officer Jennifer Kent sold 22,940 shares at $24.00 (~$551K) under a Rule 10b5-1 plan, retaining 188,572 shares
- Agios Pharmaceuticals (AGIO) (BEARISH)▲
CMO Sarah Gheuens sold 1,489 shares at $37.53 (~$55.9K) after exercising options at $25.01, six transactions in total under a 10b5-1 plan
Risk Flags (7)
- ▼
Three senior executives (Toczydlowski, Rowland, Klenk) collectively sold roughly 46,700 shares (~$19M) in one filing window, with each pairing option exercises with same-day sales, a pattern that can signal liquidity-driven rather than conviction-driven selling
- InnovAge/Sponsor Exit Risk↓ [HIGH RISK]▼
IGNITE AGGREGATOR LP, a 10%+ holder, sold $13.9M of stock at $9.25 while retaining roughly 101M shares, creating an overhang that could pressure the float if further block sales follow
- Sea Ltd/Option-Driven Liquidity↓ [MEDIUM RISK]▼
President Feng's exercise of 1,000,000 options at $15.00 (~$15M) with immediate retention of shares is an insider cash-to-equity conversion; watch for follow-on sales if the position is liquidated
- Kohl's/Legal Officer Selling [MEDIUM RISK]▼
Sale of 22,940 shares at $24.00 by Chief Legal & Corporate Affairs Officer Jennifer Kent, a control-function executive, during a period where retail peers face pressure, merits monitoring
- Agios/Clinical-Stage Selling↓ [MEDIUM RISK]▼
CMO selling under a 10b5-1 plan combined with multiple option exercises may reflect diversification ahead of pipeline catalysts; the pattern deserves cross-checking against trial timelines
- Verizon/Phantom Stock Overhang↓ [LOW RISK]▼
Multiple Verizon executives received phantom stock awards at $12.91; these are compensation-driven and low signal, but cumulative awards across the consumer and business segments increase dilution-like pressure on executive alignment metrics
- Waste Energy/Insider Price Ambiguity↓ [MEDIUM RISK]▼
Chairman's acquisition at $0.00 per share (219,286 shares) lacks a clear arms-length price, which warrants verification of whether this reflects a grant, conversion, or related-party transfer before treating it as a buy signal
Opportunities (7)
- Rent the Runway/Insider Cluster Buy↓ (OPPORTUNITY)◆
Nexus Capital (director-affiliated) and CHS US Investments (10% owner) both bought at $3.55 on the same date, totaling ~$3.9M of coordinated accumulation; the cluster of two significant holders buying at the same price is a stronger signal than single-insider purchases
- AIM ImmunoTech/Micro-Cap Insider Accumulation↓ (OPPORTUNITY)◆
CEO open-market purchase at $0.16 is a rare high-conviction signal in an illiquid name; the purchase size is small in dollar terms but meaningful relative to the price level and company float
- Cascade Real Assets Fund/NAV-Discount Alignment↓ (OPPORTUNITY)◆
Director Worley's $431K purchase at $10.29 per Class I share directly aligns a fund director with shareholders at the current NAV, a positive governance signal for closed-end or interval fund investors
- Vista Credit Strategic Lending/Management Alignment↓ (OPPORTUNITY)◆
CEO Galligan's $100K purchase at $19.44, bringing holdings above 43,000 shares, supports the private-credit BDC thesis that management has skin in the game
- Baozun/Insider Buying at Depressed Price↓ (OPPORTUNITY)◆
CEO Qiu Wenbin's repeated purchases at $3.50 per ADS signal management view that the stock is undervalued near current levels; watch for a catalyst such as quarterly results to validate the thesis
- Mexico Equity & Income Fund/Activist Accumulation↓ (OPPORTUNITY)◆
Saba Capital bought 2,000 shares at $20.14 (~$40.3K), building a position of 2.42M shares; Saba is a known discount-capture activist in closed-end funds, so accumulation may precede a tender or governance push
- PIMCO Dynamic Income/Activist Trimming↓ (OPPORTUNITY)◆
Saba sold 2,700 shares at $20.50 and 1,100 at $20.47 while holding 6.02M shares, suggesting profit-taking at a premium to NAV; this is a relative-value signal worth tracking against the PDI discount level
Sector Themes (6)
- Insurance Executive Liquidity Event (BEARISH)◆
Travelers executives across three business lines (Business Insurance, Bond & Specialty, Chief Investment Officer) exercised options at $132.58 and sold near $404-$406, an aggregate of roughly $19M in a single filing window, pointing to a coordinated liquidity event rather than isolated trades; implications include potential read-through for peer insurers where stock has run materially above option strike prices
- Closed-End Fund Activist Activity (MIXED)◆
Saba Capital appears in three filings (Mexico Equity & Income, PIMCO Dynamic Income, plus fund-level exposure), buying in one and selling in another, which indicates active discount arbitrage across the closed-end fund complex; investors in CEF names trading below NAV should monitor 10%-holder filings for tender or activism catalysts
- Routine Director Equity Compensation Dominates Volume (NEUTRAL)◆
Roughly 20 of the 50 filings (Odysseus RSUs, KKR Class F awards, EQT Class T, John Wiley phantom units, Verizon phantom stock, Arcosa and Mattel RSU grants) are compensation awards with no open-market transaction; these inflate filing counts but should be excluded from sentiment scoring
- Arcosa Director Share Disposals to Issuer (NEUTRAL)◆
Two Arcosa directors (Craig Jeffrey A and Trent Melanie Montague, plus Lubel Kimberly S) disposed of shares to the issuer at $150.00, totaling roughly $6.7M across three filings, consistent with a tender, buyback, or deferred-compensation settlement at a fixed price; the uniform $150.00 price points to a corporate transaction rather than market trading
- 10b5-1 Plan Prevalence in Sales (NEUTRAL)◆
At least six sales (Semtech, BETA Technologies, Sea Ltd, Kohl's, Agios, and portions of Travelers activity) were reported under Rule 10b5-1 plans, reducing their informational value as discretionary bearish signals; investors should weight pre-scheduled sales lower than unscheduled sales
- Asset Manager Director Co-Investment (BULLISH)◆
Fund-level directors buying shares at or near NAV (Cascade Real Assets, Vista Credit, First Financial Corp) indicate a broader pattern of governance alignment among regional banks and closed-end vehicles, which tends to be read positively by income-oriented allocators
Watch List (8)
- Travelers Companies (TRV)👁
Monitor further executive sales above $400 and any 10b5-1 plan disclosures in upcoming Form 4s; the concentration of three EVP-level sales in one window warrants checking whether plan adoption dates explain the timing
- InnovAge (INNV)👁
Track IGNITE AGGREGATOR LP's remaining 101M-share position for follow-on block sales; a second tranche at or near $9.25 would signal sustained sponsor exit
- Rent the Runway (RENT)👁
Watch whether the $3.55 purchase cluster from Nexus Capital and CHS US Investments signals a take-private or strategic transaction, given the coordinated pricing by two large holders
-
Monitor President Feng's retained 2.0M shares for any subsequent sales following the 1M-option exercise at $15.00, which would indicate a monetization cycle rather than retention
- Agios Pharmaceuticals (AGIO)👁
Cross-reference CMO Gheuens' six-transaction 10b5-1 sale program against upcoming clinical readouts or regulatory milestones to assess whether selling is pre-catalyst diversification
- Saba Capital / Closed-End Fund Complex👁
Track Saba's accumulation in Mexico Equity & Income (2.42M shares) and reduction in PIMCO Dynamic Income (6.02M shares) for signs of tender offers, proxy activity, or NAV-discount trades
-
Verify the nature of the Chairman's $0.00 share acquisition (219,286 shares) through the full Form 4 footnotes before drawing conclusions from the 9.5M-share holding
- Kohl's (KSS)👁
Monitor additional Chief Legal Officer sales and whether the 10b5-1 plan is part of a broader executive selling pattern across the retail sector
Filing Analyses
(50)
23-10-2026
Director Craig Jeffrey A disposed to the issuer 19,931 Common Stock at $150.00 (~$2.99M).
- · Director Craig Jeffrey A disposed to the issuer 19,931 Common Stock at $150.00 (~$2.99M)
23-10-2026
Director Schmitz Ronald D. was awarded 317.597 Class F Common Stock. Schmitz Ronald D. holds 5,390.076 shares after the transaction.
- · Director Schmitz Ronald D. was awarded 317.597 Class F Common Stock
23-10-2026
President and Chief Op Officer Merriwether Deidra C was awarded 31,042 Common Stock. Merriwether Deidra C holds 31,042 shares after the transaction.
- · President and Chief Op Officer Merriwether Deidra C was awarded 31,042 Common Stock
23-10-2026
Director SCHNABEL SUSAN C was awarded 952.792 Class F Common Stock. SCHNABEL SUSAN C holds 12,940.111 shares after the transaction.
- · Director SCHNABEL SUSAN C was awarded 952.792 Class F Common Stock
23-10-2026
10% owner IGNITE AGGREGATOR LP sold 1,500,000 Common Stock, $0.001 par value at $9.25 (~$13.9M). IGNITE AGGREGATOR LP holds 101,076,555 shares after the transaction.
- · 10% owner IGNITE AGGREGATOR LP sold 1,500,000 Common Stock, $0.001 par value at $9.25 (~$13.9M)
23-10-2026
Director Sanchez Ramiro bought 3,600 Common Stock at $27.35 (~$98.5K). Sanchez Ramiro holds 3,600 shares after the transaction.
- · Director Sanchez Ramiro bought 3,600 Common Stock at $27.35 (~$98.5K)
23-10-2026
Director Grinberg Paul was awarded 44,335 Restricted Stock Units.
- · Director Grinberg Paul was awarded 44,335 Restricted Stock Units
23-10-2026
Director Curtis Barry was awarded 378.1983 Class T Shares. Curtis Barry holds 3,338.139 shares after the transaction.
- · Director Curtis Barry was awarded 378.1983 Class T Shares
23-10-2026
Director Myers Christopher D was awarded 44,335 Restricted Stock Units.
- · Director Myers Christopher D was awarded 44,335 Restricted Stock Units
23-10-2026
Director Walsh Paul V Jr sold 500 Common Stock at $139.44 (~$69.7K). Walsh Paul V Jr holds 26,100 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Walsh Paul V Jr sold 500 Common Stock at $139.44 (~$69.7K)
23-10-2026
Director Pham Caroline D. was awarded 44,335 Restricted Stock Units.
- · Director Pham Caroline D. was awarded 44,335 Restricted Stock Units
23-10-2026
Principal Accounting Officer Cobo Marc had withheld for taxes 203 Common Stock at $2.68 (~$544). Cobo Marc holds 13,812 shares after the transaction.
- · Principal Accounting Officer Cobo Marc had withheld for taxes 203 Common Stock at $2.68 (~$544)
23-10-2026
Director Willis Martha was awarded 378.1983 Class T Shares. Willis Martha holds 3,338.139 shares after the transaction.
- · Director Willis Martha was awarded 378.1983 Class T Shares
23-10-2026
10% owner Helena Global Investment Opportunities 1 Ltd. disposed to the issuer 7,345,809 Common Shares.
- · 10% owner Helena Global Investment Opportunities 1 Ltd. disposed to the issuer 7,345,809 Common Shares
23-10-2026
CEO, CHAIRMAN OF BOARD DILLARD WILLIAM T II gifted 50,000 Common Class A. DILLARD WILLIAM T II holds 857,948 shares after the transaction.
- · CEO, CHAIRMAN OF BOARD DILLARD WILLIAM T II gifted 50,000 Common Class A
23-10-2026
Director Dobson David C was awarded 228 Phantom Stock Units at $54.04 (~$12.3K).
- · Director Dobson David C was awarded 228 Phantom Stock Units at $54.04 (~$12.3K)
23-10-2026
Director Singh Inder M was awarded 122 Phantom Stock Units at $54.04 (~$6.59K).
- · Director Singh Inder M was awarded 122 Phantom Stock Units at $54.04 (~$6.59K)
23-10-2026
General Counsel and Secretary Cassidy Charles D had withheld for taxes 406 Series 1 Common Stock at $3.62 (~$1.47K). Cassidy Charles D holds 164,637 shares after the transaction.
- · General Counsel and Secretary Cassidy Charles D had withheld for taxes 406 Series 1 Common Stock at $3.62 (~$1.47K)
23-10-2026
Mendez Rebollo Alberto exercised/converted 0 Class A Ordinary Shares. Mendez Rebollo Alberto holds 2,127,283 shares after the transaction.
- · Mendez Rebollo Alberto exercised/converted 0 Class A Ordinary Shares
23-10-2026
EVP and Group CEO-VZ Consumer Villanueva Rodriguez Alfonso was awarded 134.656 Phantom Stock (unitized) at $12.91 (~$1.74K).
- · EVP and Group CEO-VZ Consumer Villanueva Rodriguez Alfonso was awarded 134.656 Phantom Stock (unitized) at $12.91 (~$1.74K)
23-10-2026
EVP and Chief Legal Officer Venkatesh Vandana was awarded 98.907 Phantom Stock (unitized) at $12.91 (~$1.28K).
- · EVP and Chief Legal Officer Venkatesh Vandana was awarded 98.907 Phantom Stock (unitized) at $12.91 (~$1.28K)
23-10-2026
SEE REMARKS Clark Kyle sold 10,000 Class A common stock at $19.06 (~$191K). Clark Kyle holds 5,025,936 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · SEE REMARKS Clark Kyle sold 10,000 Class A common stock at $18.38 (~$184K)
- · SEE REMARKS Clark Kyle sold 10,000 Class A common stock at $19.06 (~$191K)
- · SEE REMARKS Clark Kyle sold 10,000 Class A common stock at $18.48 (~$185K)
23-10-2026
EVP and Group CEO-VZ Business Malady Kyle was awarded 134.656 Phantom Stock (unitized) at $12.91 (~$1.74K).
- · EVP and Group CEO-VZ Business Malady Kyle was awarded 134.656 Phantom Stock (unitized) at $12.91 (~$1.74K)
23-10-2026
EVP, COO THOMA GINA N. was awarded 1,675 Common Stock. THOMA GINA N. holds 36,319 shares after the transaction.
- · EVP, COO THOMA GINA N. was awarded 1,675 Common Stock
23-10-2026
10% owner Scott Jonathan R sold 5,000 Common Stock at $36.90 (~$185K). Scott Jonathan R holds 812,738 shares after the transaction.
- · 10% owner Scott Jonathan R sold 5,000 Common Stock at $36.90 (~$185K)
23-10-2026
CCO and GC Wang Yanjun sold 569 Class A ordinary shares at $76.09 (~$43.3K). 7 transactions reported in total. Wang Yanjun holds 74,380 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · CCO and GC Wang Yanjun sold 316 Class A ordinary shares at $76.90 (~$24.3K)
- · CCO and GC Wang Yanjun sold 324 Class A ordinary shares at $77.68 (~$25.2K)
- · CCO and GC Wang Yanjun sold 96 Class A ordinary shares at $78.67 (~$7.55K)
- · CCO and GC Wang Yanjun sold 64 Class A ordinary shares at $79.59 (~$5.09K)
- · CCO and GC Wang Yanjun sold 569 Class A ordinary shares at $76.09 (~$43.3K)
- · CCO and GC Wang Yanjun sold 225 Class A ordinary shares at $76.91 (~$17.3K)
- · CCO and GC Wang Yanjun sold 6 Class A ordinary shares at $77.60 (~$466)
23-10-2026
President Feng Zhimin exercised/converted 1,000,000 Class A ordinary shares at $15.00 (~$15M). Feng Zhimin holds 2,003,969 shares after the transaction.
- · President Feng Zhimin exercised/converted 1,000,000 Class A ordinary shares at $15.00 (~$15M)
- · President Feng Zhimin exercised/converted 1,000,000 Share options (right to buy)
23-10-2026
10% owner JPMorgan Chase Bank, N.A. disposed of 990 Series C MuniFund Preferred Shares. JPMorgan Chase Bank, N.A. holds 990 shares after the transaction.
- · 10% owner JPMorgan Chase Bank, N.A. disposed of 990 Series C MuniFund Preferred Shares
- · 10% owner JPMorgan Chase Bank, N.A. acquired 990 Series C MuniFund Preferred Shares
23-10-2026
Director Matheson Lee was awarded 6,883 Restricted Stock Units.
- · Director Matheson Lee was awarded 6,883 Restricted Stock Units
23-10-2026
Chief Executive Officer Qiu Wenbin bought 5,700 American Depositary Shares at $3.50 (~$20K). Qiu Wenbin holds 1,695,772 shares after the transaction.
- · Chief Executive Officer Qiu Wenbin bought 5,700 American Depositary Shares at $3.50 (~$20K)
- · Chief Executive Officer Qiu Wenbin bought 5,700 American Depositary Shares at $3.50 (~$20K)
23-10-2026
10% owner Saba Capital Management, L.P. bought 2,000 Common Stock at $20.14 (~$40.3K). Saba Capital Management, L.P. holds 2,424,660 shares after the transaction.
- · 10% owner Saba Capital Management, L.P. bought 2,000 Common Stock at $20.14 (~$40.3K)
23-10-2026
VP, Animal Health Hastings Gregory S exercised/converted 287 Common Stock at $12.00 (~$3.44K). Hastings Gregory S holds 32,575 shares after the transaction.
- · VP, Animal Health Hastings Gregory S exercised/converted 287 Common Stock at $12.00 (~$3.44K)
- · VP, Animal Health Hastings Gregory S had withheld for taxes 80 Common Stock at $12.00 (~$960)
- · VP, Animal Health Hastings Gregory S exercised/converted 287 Restricted Stock Units at $12.00 (~$3.44K)
23-10-2026
Director Trent Melanie Montague disposed to the issuer 17,931 Common Stock at $150.00 (~$2.69M).
- · Director Trent Melanie Montague disposed to the issuer 17,931 Common Stock at $150.00 (~$2.69M)
23-10-2026
CEO and President GALLIGAN GREGORY T bought 5,143.644 Common Stock at $19.44 (~$100K). GALLIGAN GREGORY T holds 43,446.644 shares after the transaction.
- · CEO and President GALLIGAN GREGORY T bought 5,143.644 Common Stock at $19.44 (~$100K)
23-10-2026
Director Lubel Kimberly S disposed to the issuer 6,546 Common Stock at $150.00 (~$982K).
- · Director Lubel Kimberly S disposed to the issuer 6,546 Common Stock at $150.00 (~$982K)
23-10-2026
Director McDonald James O bought 86.61 First Financial Corp Stock at $73.58 (~$6.37K). McDonald James O holds 11,927.95 shares after the transaction.
- · Director McDonald James O bought 86.61 First Financial Corp Stock at $73.58 (~$6.37K)
23-10-2026
EVP, CFO Oakes Patrick Timothy was awarded 1,910 Common Stock. Oakes Patrick Timothy holds 39,716 shares after the transaction.
- · EVP, CFO Oakes Patrick Timothy was awarded 1,910 Common Stock
23-10-2026
CEO SCHULMAN DANIEL H was awarded 206.156 Phantom Stock (unitized) at $12.91 (~$2.66K).
- · CEO SCHULMAN DANIEL H was awarded 206.156 Phantom Stock (unitized) at $12.91 (~$2.66K)
23-10-2026
10% owner Saba Capital Management, L.P. sold 2,700 Common Stock at $20.50 (~$55.4K). Saba Capital Management, L.P. holds 6,022,547 shares after the transaction.
- · 10% owner Saba Capital Management, L.P. sold 2,700 Common Stock at $20.50 (~$55.4K)
- · 10% owner Saba Capital Management, L.P. sold 1,100 Common Stock at $20.47 (~$22.5K)
23-10-2026
Chairman & CEO GALLAGHER SCOTT bought 219,286 Common at $0.00 (~$219). GALLAGHER SCOTT holds 9,500,000 shares after the transaction.
- · Chairman & CEO GALLAGHER SCOTT bought 219,286 Common at $0.00 (~$219)
23-10-2026
Pres., CEO MORDELL MARK DANIEL was awarded 3,105 Common Stock. MORDELL MARK DANIEL holds 238,197 shares after the transaction.
- · Pres., CEO MORDELL MARK DANIEL was awarded 3,105 Common Stock
23-10-2026
Director Worley Matthew Eugene bought 41,909.531 Class I Shares at $10.29 (~$431K). Worley Matthew Eugene holds 41,909.531 shares after the transaction.
- · Director Worley Matthew Eugene bought 41,909.531 Class I Shares at $10.29 (~$431K)
23-10-2026
CEO & President Equels Thomas K bought 31,250 Common Stock at $0.16 (~$5.09K). Equels Thomas K holds 158,072 shares after the transaction.
- · CEO & President Equels Thomas K bought 31,250 Common Stock at $0.16 (~$5.09K)
23-10-2026
Chief Legal & Corp Affairs Off Kent Jennifer J. sold 22,940 Common Stock at $24.00 (~$551K). Kent Jennifer J. holds 188,572 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Legal & Corp Affairs Off Kent Jennifer J. sold 22,940 Common Stock at $24.00 (~$551K)
23-10-2026
Director Nexus Capital Management LP bought 632,922 Class A Common Stock, $0.001 par value per share at $3.55 (~$2.25M). Nexus Capital Management LP holds 4,907,316 shares after the transaction.
- · Director Nexus Capital Management LP bought 632,922 Class A Common Stock, $0.001 par value per share at $3.55 (~$2.25M)
23-10-2026
EVP & President, Business Ins. Toczydlowski Gregory C sold 32,671 Common Stock at $403.86 (~$13.2M). 4 transactions reported in total. Toczydlowski Gregory C holds 18,416.187 shares after the transaction.
- · EVP & President, Business Ins. Toczydlowski Gregory C exercised/converted 34,771 Common Stock at $140.85 (~$4.9M)
- · EVP & President, Business Ins. Toczydlowski Gregory C sold 32,671 Common Stock at $403.86 (~$13.2M)
- · EVP & President, Business Ins. Toczydlowski Gregory C sold 2,100 Common Stock at $404.43 (~$849K)
- · EVP & President, Business Ins. Toczydlowski Gregory C exercised/converted 34,771 Stock Options (Right to Buy)
23-10-2026
10% owner CHS US Investments LLC bought 458,245 Class A Common Stock, $0.001 par value per share at $3.55 (~$1.63M). CHS US Investments LLC holds 22,937,292 shares after the transaction.
- · 10% owner CHS US Investments LLC bought 458,245 Class A Common Stock, $0.001 par value per share at $3.55 (~$1.63M)
23-10-2026
EVP & Co-Chief Invest. Officer Rowland David Donnay sold 5,000 Common Stock at $405.62 (~$2.03M). Rowland David Donnay holds 10,478.629 shares after the transaction.
- · EVP & Co-Chief Invest. Officer Rowland David Donnay exercised/converted 5,000 Common Stock at $132.58 (~$663K)
- · EVP & Co-Chief Invest. Officer Rowland David Donnay sold 5,000 Common Stock at $405.62 (~$2.03M)
- · EVP & Co-Chief Invest. Officer Rowland David Donnay exercised/converted 5,000 Stock Options (Right to Buy)
23-10-2026
Chief Medical Officer Gheuens Sarah sold 1,489 Common stock at $37.53 (~$55.9K). 6 transactions reported in total. Gheuens Sarah holds 54,645 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Medical Officer Gheuens Sarah exercised/converted 1,489 Common stock at $25.01 (~$37.2K)
- · Chief Medical Officer Gheuens Sarah sold 1,489 Common stock at $37.53 (~$55.9K)
- · Chief Medical Officer Gheuens Sarah exercised/converted 500 Common stock at $25.01 (~$12.5K)
- · Chief Medical Officer Gheuens Sarah sold 500 Common stock at $37.52 (~$18.8K)
- · Chief Medical Officer Gheuens Sarah exercised/converted 1,489 Stock options (right to buy)
- · Chief Medical Officer Gheuens Sarah exercised/converted 500 Stock options (right to buy)
23-10-2026
EVP & Pres., Bond & Spec. Ins. Klenk Jeffrey P. sold 9,016 Common Stock at $405.57 (~$3.66M). Klenk Jeffrey P. holds 6,075.303 shares after the transaction.
- · EVP & Pres., Bond & Spec. Ins. Klenk Jeffrey P. exercised/converted 9,016 Common Stock at $132.58 (~$1.2M)
- · EVP & Pres., Bond & Spec. Ins. Klenk Jeffrey P. sold 9,016 Common Stock at $405.57 (~$3.66M)
- · EVP & Pres., Bond & Spec. Ins. Klenk Jeffrey P. exercised/converted 9,016 Stock Options (Right to Buy)
Get daily alerts with 11 investment signals, 7 risk alerts, 7 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: USA Insider Trading Pulse
🇺🇸 More from United States
View all →October 23, 2026
US Pre-Market SEC Filings Roundup — October 23, 2026
US Pre-Market SEC Filings Roundup
October 23, 2026
US Merger & Acquisition SEC Filings — October 23, 2026
US Merger & Acquisition SEC Filings
October 22, 2026
US Pre-Market SEC Filings Roundup — October 22, 2026
US Pre-Market SEC Filings Roundup
October 22, 2026
US Merger & Acquisition SEC Filings — October 22, 2026
US Merger & Acquisition SEC Filings